Hotstocked Newsletters

Promoted Companies

PROMOTION HISTORY
SORT BY:

Chelsea Therapeutics International Ltd. (CHTP)

Total paid for Promotions this month: $0
E-mails this Month: 6
Estimated Volume Generated: $0
Research Report on CHTP: Click to see
* The information presented is based on information for Jan , 2014
  Dear Profit Reader PRESS RELEASEJan. 14, 2014, 5:09 p.m. ESTFDA Advisory Panel Recommends Approval of Chelsea Therapeutics' NORTHERA(TM) (Droxidopa) for the Treatment of Symptomatic nOHCHARLOTTE, N.C., Jan 14, 2014 (GLOBE NEWSWIRE via COMTEX) -- Chelsea Therapeutics International, Ltd. CHTP +156.52% today announced that the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) ...read more
Promoter: Wall Street Breakouts Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
CHTP Unknown compensation UNKNOWN
Max Profit: 0.35 % Gain at close: -23.44 %
FDA Advisory Panel Recommendation Could Change Its Trading Levels (Mailing list information, including unsubscription instructions, is located at the end of this message.)   Chelsea Therapeutics International, Ltd. (CHTP)   Symptomatic neurogenic orthostatic hypotension (nOH) is a chronic disorder that is caused by an underlying neurogenic disorder, such as Parkinson's disease, multiple system atrophy or pure autonomic failure.   Symptoms ...read more
Promoter: pennyomega.com Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
CHTP Unknown compensation UNKNOWN
Max Profit: 0.35 % Gain at close: -23.44 %
FDA Advisory Panel Recommendation Could Change Its Trading Levels (Mailing list information, including unsubscription instructions, is located at the end of this message.)   Chelsea Therapeutics International, Ltd. (CHTP)   Symptomatic neurogenic orthostatic hypotension (nOH) is a chronic disorder that is caused by an underlying neurogenic disorder, such as Parkinson's disease, multiple system atrophy or pure autonomic failure.   Symptoms ...read more
Promoter: penny to buck Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
CHTP Unknown compensation UNKNOWN
Max Profit: 0.35 % Gain at close: -23.44 %
FDA Advisory Panel Recommendation Could Change Its Trading Levels (Mailing list information, including unsubscription instructions, is located at the end of this message.)   Chelsea Therapeutics International, Ltd. (CHTP)   Symptomatic neurogenic orthostatic hypotension (nOH) is a chronic disorder that is caused by an underlying neurogenic disorder, such as Parkinson's disease, multiple system atrophy or pure autonomic failure.   Symptoms ...read more
Promoter: stockbling.com Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
CHTP Unknown compensation UNKNOWN
Max Profit: 0.35 % Gain at close: -23.44 %
FDA Advisory Panel Recommendation Could Change Its Trading Levels (Mailing list information, including unsubscription instructions, is located at the end of this message.)   Chelsea Therapeutics International, Ltd. (CHTP)   Symptomatic neurogenic orthostatic hypotension (nOH) is a chronic disorder that is caused by an underlying neurogenic disorder, such as Parkinson's disease, multiple system atrophy or pure autonomic failure.   Symptoms ...read more
Promoter: Crwefinance.com Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
CHTP Unknown compensation UNKNOWN
Max Profit: 0.35 % Gain at close: -23.44 %
FDA Advisory Panel Recommendation Could Change Its Trading Levels (Mailing list information, including unsubscription instructions, is located at the end of this message.)   Chelsea Therapeutics International, Ltd. (CHTP)   Symptomatic neurogenic orthostatic hypotension (nOH) is a chronic disorder that is caused by an underlying neurogenic disorder, such as Parkinson's disease, multiple system atrophy or pure autonomic failure.   Symptoms ...read more
Promoter: Double in stocks Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
CHTP Unknown compensation UNKNOWN
Max Profit: 0.35 % Gain at close: -23.44 %
Video not found or You must install the Flash Plugin for your Browser in order to view this movie